Jeffrey G. Lamothe
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey G. Lamothe
Jeffrey G. Lamothe is recorded as COO and CEO at Aptevo Therapeutics Inc. (APVO). Aptevo Therapeutics Inc. reported in an 8-K filed March 7, 2023 that Jeffrey G. Lamothe was appointed Executive Vice President, Chief Operating Officer, effective March 3, 2023. The proxy statement of Aptevo Therapeutics Inc. reports total compensation of $1,020,205 for Jeffrey G. Lamothe in fiscal 2025, including a base salary of $536,008. Disclosed compensation is on record for 3 fiscal years.
“On March 3, 2023, Aptevo Therapeutics Inc. (the "Company") appointed Jeffrey G. Lamothe, formerly the Company's Executive Vice President, Chief Financial Officer, to Executive Vice President, Chief Operating Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2022-04-27
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aptevo Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Barbara Lopez Kunz CEO, Board Member
- Daniel J. Abdun-Nabi CEO, Board Member
- Jeff Lamothe CEO, Board Member
- Zsolt Harsanyi CEO, Board Member
- John E. Niederhuber Chairman, Board Member
- John Niederhuber, M.D. Chairman
- Marvin L. White Chairman, Board Member
- Daphne Taylor CFO
- SoYoung Kwon General Counsel
- Grady Grant Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aptevo Therapeutics Inc. (APVO) | Executive Vice President and Chief Operating Officer | $536,008 | $1,020,205 |
| 2019 | Aptevo Therapeutics Inc. (APVO) | Senior Vice President and Chief Financial Officer | $390,196 | $641,192 |
| 2018 | Aptevo Therapeutics Inc. (APVO) | Senior Vice President and Chief Financial Officer | $402,903 | $691,987 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.